LC-MS/MS quantitative determination of Tetrapterys mucronata alkaloids, a plant occasionally used in ayahuasca preparation.
M M F Queiroz, G Marti, E F Queiroz, L Marcourt, I Castro-Gamboa, V S Bolzani, J-L Wolfender
Phytochemical Analysis 2015 DOI: 10.1002/pca.2548 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Quantitative analysis Peer reviewed |
|---|---|
| Population | Stem bark of Tetrapterys mucronata |
| Topics | Ayahuasca |
| Keywords | 5-methoxy-bufotenine Hplc-esi/ms/ms quantitation Phytochemistry: chemical profile Potent compounds Bark extracts Ayahuasca-mimicking decoctions Psychoactive compounds: bufotenine Tetrapterys mucronata: malpighiaceae Plant |
| Citations | 11 |
| Key points | The bark of Tetrapterys mucronata contains substantial levels of bufotenine and 5-methoxy-bufotenine, suggesting that its use in ayahuasca preparations may present a risk to consumers. |
Abstract
Tetrapterys mucronata Cav. (Malpighiaceae) is a plant used in some regions of Brazil in the preparation of ayahuasca. To determine the content of the main tryptamine alkaloids in the stem bark of T. mucronata Cav. and assess their possible toxic and hallucinogenic properties based on the doses found in a water decoction that mimics the ayahuasca preparation. Four alkaloids previously described for their toxic and hallucinogenic properties were quantitated by multiple reaction monitoring HPLC combined with electrospray ionisation and tandem MS (HPLC-ESI/MS/MS) in the water decoction and ethanolic extracts from the bark of T. mucronata. Exhaustive extraction of the stem barks with ethanol revealed the following alkaloid levels: bufotenine (1) 3.26 ± 0.31 mg/g, 5-methoxy-N-methyltryptamine (2) 0.88 ± 0.08 mg/g, 5-methoxy-bufotenine (3) 3.07 ± 0.22 mg/g and 2-methyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline (4) 0.14 ± 0.004 mg/g. The water decoction presented slightly lower levels, ranging between 2.32 ± 0.14, 0.50 ± 0.04, 1.53 ± 0.09 and 0.10 ± 0.01 mg/g for (1), (2), (3) and (4) respectively. The HPLC-ESI/MS/MS quantitation revealed significant alkaloid levels, in particular for bufotenine and 5-methoxy-bufotenine. As such compounds are known for their toxic and hallucinogenic properties, these results indicate that the consumption of this plant as an ingredient in ayahuasca preparations may present a risk to consumers.
Citations in the library
Cited by 4
- Ayahuasca: Uses, Phytochemical and Biological Activities Natural Products and Bioprospecting May 27, 2019
- Evaluation of the Cytotoxicity of Ayahuasca Beverages Molecules November 28, 2020
- Unveiling ayahuasca: Comprehensive Study of Botanical and Chemical Diversity. Journal of Ethnopharmacology September 24, 2026
- Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures. Forensic Science International September 2016
Cites 15
- Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Journal of Ethnopharmacology April 1, 1984
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics May 1, 2004
- Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Current Drug Metabolism October 1, 2010
and 10 more in the library